AstraZeneca Plc plans to invest $50 billion in the US before 2030, ratcheting up spending alongside other European drugmakers ...

With Richard Ayoade with David Letterman, Robert Downey Jr., Kamilah Forbes, Scott Galloway, Tom Hanks, Becky Kennedy, and ...

Few things can jolt a pharmaceutical company's shares like positive results from highly anticipated clinical trials. Even so, ...

As a pro athlete, Caitlin Clark has access to some of the most innovative wellness treatments—red-light therapy, dry needling ...

Eli Lilly & Co. closed 20.16% below its 52-week high of $972.53, which the company achieved on August 22nd.

Pharmaceutical giant Eli Lilly delivers strong financial results and has a deep lineup and pipeline. Much smaller Viking Therapeutics boasts several candidates whose progress could jolt its shares.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

The best stocks to invest in often are industry leaders in vast markets. These five stocks are likely to continue making ...

Kiran Musunuru, a University of Pennsylvania cardiologist and leading gene-editing researcher, thinks it’s possible. Musunuru cofounded Verve Therapeutics, a company developing a therapy that uses ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

The money will focus on a manufacturing plant in Virginia that will make the company's weight management and metabolic drugs ...

Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science ...